Novel targeted therapies in acute lymphoblastic leukemia
CA Portell, AS Advani - Leukemia & lymphoma, 2014 - Taylor & Francis
Abstract Chemotherapy alone cures only 25–45% of adult patients with acute lymphoblastic
leukemia (ALL), making novel treatment agents and strategies desperately needed. The …
leukemia (ALL), making novel treatment agents and strategies desperately needed. The …
Novel therapeutic strategies in acute lymphoblastic leukemia
A Dias, SJ Kenderian, GF Westin, MR Litzow - Current hematologic …, 2016 - Springer
Chemotherapy cures only a minority of adult patients with acute lymphoblastic leukemia
(ALL). In addition, relapsed ALL has a poor outcome with 5-year survival as low as 7 …
(ALL). In addition, relapsed ALL has a poor outcome with 5-year survival as low as 7 …
Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development
SA Parikh, MR Litzow - Future Oncology, 2014 - Future Medicine
Although the prognosis of adults with Philadelphia chromosome-negative acute
lymphoblastic leukemia (ALL) has steadily improved over the past decade, less than 50% of …
lymphoblastic leukemia (ALL) has steadily improved over the past decade, less than 50% of …
[PDF][PDF] 雷利度胺治疗难治复发急性粒细胞白血病临床观察
孔德胜， 赵红丽， 董敏， 孙国勋， 施婺丹， 洪珞珈 - 2012 - biomed.cnjournals.com
摘要目的: 观察雷利度胺治疗难治复发急性粒细胞白血病的疗效及不良反应. 方法:
给予雷利度胺单药治疗, 雷利度胺50mg/d, 口服给药, 连续给药21 天, 28 天为一个疗程. 结果 …
给予雷利度胺单药治疗, 雷利度胺50mg/d, 口服给药, 连续给药21 天, 28 天为一个疗程. 结果 …
雷替曲塞治疗难治复发白血病临床观察
孔德胜， 赵红丽， 于雪， 董敏， 张颖， 沈慧君， 洪珞珈 - 重庆医科大学学报, 2013 - cqvip.com
白血病是血液系统常见的恶性肿瘤. 在我国35 岁以下的恶性肿瘤患者中, 白血病是导致死亡的
主要原因. 目前, 白血病的治疗已经取得了很大进展, 通过化疗, 造血干细胞移植 …
主要原因. 目前, 白血病的治疗已经取得了很大进展, 通过化疗, 造血干细胞移植 …